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Results
At 12 months, the change in mean morning peak expiratory flow, as compared with baseline, did not differ between the mechanical ventilation group and the control group [mean difference 13.5 liters per minute, 95% CI. -2.6 to 29.8, p=0.100].
However, evening mean peak expiratory flow was significantly improved in the mechanical ventilation group [mean difference 24.5 liters per minute, 95% CI. 8.9 to 40.1, p=0.002] and there were fewer hospitalizations for asthma (0 vs. 4, p=0.029).
Indoor relative humidity was reduced in mechanically ventilated homes, but there was no difference between the groups in Der p 1 levels, compared with baseline, to account for the clinical changes.
Conclusions
The addition of mechanical heat recovery ventilation to conventional house dust mite eradication strategies did not achieve a reduction in house dust mite levels, but did improve some indices of asthma control.
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INTRODUCTION
The prevalence of asthma in the western world has increased over the last generation, 1 in parallel with a warmer indoor microclimate. 2 Increased insulation, double glazing and modern building construction have improved standards of heating and energy efficiency in homes, but with reduced ventilation. 3 A warm, humid indoor environment favours the growth of the house dust mite population. 4 Sensitivity to the house dust mite is the most common allergy associated with asthma in the UK. 5 Studies of occupational asthma 6 and altitude 7 infer that the environment may directly affect symptoms of asthma. Accordingly, allergen avoidance has been advocated as an important aspect of asthma management, yet the evidence for its efficacy is limited. 8 Large studies of conventional measures to eradicate dust mites, such as miteimpermeable mattress covers, have not shown a benefit for asthma symptoms. 9, 10 However, Morgan et al 11 found significant improvement in asthma when a number of allergens were targeted in combination with an educational intervention and smoking cessation advice.
As house dust mites thrive in moist conditions, an additional eradication strategy would be to reduce indoor air humidity by improving ventilation. Mechanical heat recovery ventilation is a method of active ventilation using both an extract and a supply fan. Outdoor air is supplied at ambient humidity into the living room and bedroom, and extracted from the kitchen and bathroom. There is evidence that mechanical ventilation reduces indoor air humidity and the house dust mite allergen burden, but the clinical effects on asthma have not been proven. 12, 13 The hypothesis is that domestic mechanical heat recovery ventilation, in addition to allergen avoidance measures, can improve asthma control of those sensitive to house dust mite allergen, by attenuating re-colonisation rates.
METHODS
Participants
Participants 16 to 60 years of age were eligible if they had asthma for more than one year, were on regular inhaled corticosteroids and had daily symptoms. Participants were recruited from general practice and hospital clinics in Lanarkshire, Scotland, UK. Variable airflow obstruction of ≥12% on spirometry 14 or ≥15% on peak expiratory flow (PEF) readings 15 or a symptom score of ≥0.86 on the Asthma Control Questionnaire (ACQ) 16, 17 was required for inclusion. Participants had a minimum forced expiratory volume in 1 second (FEV 1 ) of >50% predicted at baseline and had not had an exacerbation in the previous month. Spirometric measurements were recorded using an electronic spirometer (Vitalograph, Buckingham, UK), before and after inhaled salbutamol (400 g). 18 PEF measurements were taken at home using a mini-Wright peak flow meter (Clement Clarke, Harlow, UK 
Study design
This was a randomised, double-blind, placebo-controlled, parallel group study to evaluate the effect of home installation of mechanical heat recovery ventilation (MHRV), in addition to conventional eradication strategies, in adults with asthma who were sensitive to Dermatophagoides pteronyssinus.
MHRV system
Homes of eligible participants were surveyed to assess suitability for installation.
Homes were excluded if installation was technically difficult or if there was asbestos in ceiling materials. MHRV units (HR250 or HR800) were fitted in the roof space or hallway cupboard in 120 suitable homes by 'Vent-Axia™' (Crawley, UK). These energy efficient units extract air continuously from the kitchen and bathroom and deliver pre-warmed air via insulated ducts into the bedroom and living room ( Figure   1 ). The system provided an additional 0.5 air exchanges per hour to the living room and bedroom.
Clinical assessments
Participants attended a baseline visit where spirometry was recorded and the ACQ 16 and St. George's Respiratory Questionnaire 20 were completed. The EQ-5D and dog dander (Can f1) were measured using fluorescent multiplex array technology (Indoor Biotechnologies, Charlottesville, VA). 24 The microbial content of dust was estimated by measuring soluble extract concentrations of bacterial endotoxin and fungal β(1-3) glucan (Associates of Cape Cod Inc., East Falmouth, MA, USA).
Plasma cotinine was measured using a microplate competitive enzyme immunoassay (Cozart Bioscience Ltd, Abingdon, Oxford, U.K.),
Temperature and humidity were recorded at 90 minute intervals for 12 months in the living room and bedroom using thermohygrographs, 'Gemini Tiny Tag Ultra two channel' dataloggers (Gemini, Chichester, UK). The critical equilibrium humidity, at which no water is gained or lost by the house dust mite, is 73% relative humidity at 25ºC. 4 As maintaining relative humidity below 50% is a common recommendation for reducing dust mites in the home, 25 the proportion of time that relative humidity fell below 50% was calculated.
Allergen avoidance measures
Once baseline measurements were complete, allergen eradication took place in all homes. Carpets were cleaned with a "Medivac" steam cleaner at the rate of 1m 2 per minute (Medivac Healthcare Ltd., Cambridge, UK). New pillows, duvets and mattress covers were supplied to all participants ("Naturelle" range, Medivac Healthcare Ltd., Cambridge, UK).
Randomisation
Randomisation was performed in sequential blocks of four using an automated telephone answering system at the Robertson Centre for Biostatistics, University of Glasgow, UK, by the architect team. Accordingly, a fused electrical spur was switched in the roof space by the architect to activate half of the units. The unit activation device was concealed from the patient and the clinical research team.
Follow-up
Participants were followed up at 3, 6, 9 and 12 months after randomisation, until April 2007. Participants measured morning and evening PEF for 2 weeks before each visit.
At each visit, spirometry was performed, ACQ score was recorded and requirements for oral corticosteroids, hospitalisations, General Practice or Emergency Department visits were noted. The St. George's Respiratory questionnaire, the EuroQol questionnaire and nasal visual analogue scores and questionnaires were repeated at 6 and 12 months after randomisation. At 12 months, blood samples for IgE serology, dust samples and humidity measurements were taken and placebo units activated.
Statistical analysis
The sample size was based upon a parallel group design, using a standard deviation of 40 liters/min for mean morning PEF. The study was intended to have 64 evaluable participants per group (n=128), in order to have 80% power (at the 5% significance level) to calculate a difference of 20 liters/min.
The primary analysis was a comparison between groups of the change over baseline in morning PEF. Secondary endpoints were evening PEF, ACQ scores, exacerbation and hospitalisation rates, spirometry, quality-of-life, Der p 1 levels and humidity readings in the homes, IgE levels and economic evaluations. If 12 month data were not available, 9 month data would be used instead. The main analyses were carried out with ANCOVA models adjusted for baseline severity. The analyses were firstly carried out on an intention to treat basis. A list of 'major protocol violators' consisting of those with premature activation by the electrician and randomisation errors was created and the remaining population were denoted the 'per protocol' set. The primary and secondary endpoints were repeated for the 'per protocol' set. Binary endpoints such as hospitalizations were compared by odds-ratios, the attendant 95% confidence interval and tested by Mantel-Haenszel chi-squared test.
RESULTS
Baseline characteristics of participants
A total of 4986 participants were invited to participate, 482 attended clinical screening and 216 fulfilled the clinical entry criteria (Figure 2 ). Fifty-three subjects did not fulfill all housing criteria and 43 did not wish to have the MHRV unit installed. Units were installed in 120 homes, 119 underwent randomisation. Baseline demographic characteristics of those randomized were similar (Table 1 ).
Outcome measures
Clinical outcomes
100 participants attended follow-up at 12 months. The clinical outcome measures are listed in Table 2 differ between the MHRV group and the control group, nor were there differences in total or house-dust mite specific IgE. There were also no significant differences in secondary analyses of cat dander allergen (Fel d1), dog dander allergen (Can f1), β (1-3) glucan or endotoxin. (Table 2 )
DISCUSSION
This randomised, double-blind placebo-controlled study examined the effect of the installation of domestic mechanical heat recovery ventilation (MHRV) on asthma control in adults sensitive to house dust mite allergen. It was based on the hypothesis that a warm, humid environment favours growth of the house dust mite population and that decreasing indoor air humidity with mechanical ventilation would reduce the dust mite allergen burden and improve asthma control.
Statement of principal findings
We found that there were improvements in some indices of asthma control at 12 months: increased evening PEF and fewer hospital admissions with asthma. Indoor relative humidity was reduced in the autumn and winter months in ventilated homes, but there was no difference between Der p 1 levels between the groups to account for the clinical changes. There were improvements in ACQ and Rhinitis visual analogue scores in the MHRV group after 6 months, which were short lasting, and may imply that the MHRV intervention was most effective when combined with recent mite eradication strategies.
Strengths and weaknesses of the study
The strengths of the study are that it was a large community-based randomised trial utilising expertise from different disciplines. Participants reflected the general population with asthma with a GP diagnosis of asthma, daily symptoms and house dust mite sensitivity were sufficient for inclusion. Randomisation was effectively concealed from the participants and the clinical team. As 100 of a projected optimum number of 128 participants completed follow-up, the power of the study may not have been sufficient to detect a significant change in morning PEF.
Relation to previous research
Two previous small studies have examined the efficacy of MHRV for asthma. Warner and colleagues 12 showed a non-significant improvement in histamine PC 20 (p=0.085), but no change in lung function or symptom scores with MHRV and high energy vacuum cleaning. Htut 26 found a decrease in bronchial hyperreactivity at 12 months after MHRV and steam cleaning. Our study provides weight to the evidence that improved ventilation might have a beneficial effect on asthma control.
Although the Der p 1 and Der p 2 levels fell in both groups, there was no difference between the MHRV group and the control group, adjusted for baseline. There was no difference between the groups in change in serum house-dust mite specific IgE antibody. This suggests that the MHRV system reduced indoor relative humidity to levels that were insufficient to impact on mite levels. Maintaining relative humidity below 50% is a common recommendation for reducing dust mites in the home. 25 The MHRV unit achieved a relative humidity less than 50% in the winter months in the bedrooms more frequently than in the control group. However, although it may be statistically significant, it may not be environmentally significant as the fluctuation of humidity levels may permit mite survival. For example, a New Zealand study 27 showed that, although active ventilation did reduce relative humidity to less than 50% for 7 months of the year, there were no effects on mite levels because values were below the critical equilibrium humidity for only 39% of the total of 24-hour periods for which measurements were made. In another UK study, Fletcher 30 also found no impact of MHRV on Der p 1. It is possible that 12 months was too short a period to measure a difference in seasonally affected mite re-colonisation rates, after steam cleaning and barrier bedding were implemented across both cohorts.
One reason for this lack of efficacy in mite control may be related to climate. 29 For ventilation to reduce indoor humidity, the outdoor air humidity must be sufficiently lower than that inside. A Danish study observed 11 subjects with allergic asthma who were moved to 'healthy' homes with MHRV and found that a reduction of indoor absolute humidity was associated with a fall in dust mites and an improvement in indices of asthma control. However, there is an important difference between the cold winters of Scandinavia where the ambient air relative humidity was very low, compared with the high humidity ambient wet air during the milder winters of temperate regions of western Europe and New Zealand. Based on these observations, a future development in the intervention would be a humidistat controller (set at 50%)
linked to a variable flow fan unit to ensure humidity suppression during the colder months.
Unanswered questions and future research
As the beneficial clinical effect of MHRV is not explained by a reduction in exposure to house dust mites, which other alternative explanations can be considered? No difference in cat or dog allergens, or in bacterial endotoxin levels in dust samples was demonstrated between the groups. Maintaining relative humidity below 50% has been recommended for controlling mould. 31 Burr and co-workers recently conducted an unblinded mold eradication trial that included improved home ventilation and found symptomatic improvement in wheeze, medication use and rhinitis. 32 In our study no difference between fungal glucan exposure was observed between the groups. Other In conclusion, this randomised controlled trial has shown clinical benefits of improved home ventilation in asthma control not explained by reduced levels of house dust mites. Future research should determine the mechanism of this effect.
'What this paper adds' box
What is already known on this subject
House dust mite allergy is commonly associated with asthma. The warm, humid environment in modern homes favours the house dust mite population. The effect of improved ventilation on asthma control is not known.
What this paper adds
This randomised controlled trial has shown clinical benefits of improved home ventilation in asthma control. However, this was not explained by reduced levels of house dust mites. Future research should determine the mechanism of this effect.
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Figure 4 Relative humidity values and temperature over 12 months
The fortnightly mean (standard deviation on one-side) relative humidity and temperature in the bedroom and living room show an annual periodicity with the lowest levels in March.
MHRV reduced humidity in the bedrooms during April (* p<0.05) and then for a sustained period from October until February ( † p<0.001). The humidity in the living room was significantly reduced (* p<0.05) from December to February. There was no effect of MHRV on temperature. 
